The Normal Standard of Brainstem Auditory Evoked Potential in Adults Using a New Device

There are no differences between the exams made with the new device,that evaluates the hearing, and the device gold standard, that is widely used in clinics and hospitals.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Normal Hearing (76 Subjects) Ear Diseases Hearing Disorders Hearing Loss Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms Subjects With Hearing Loss (15 Subjects)

Age range

25 year–55 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Universidade Estadual de Ciências da Saúde de Alagoas

Maceió, Alagoas, 57010-300, Brazil

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

hearing thresholds less than 25 dB at all frequencies of pure tone audiometry, with differences between the ears, by frequency, or less than 10 dB.
The group with bilateral sensorineural hearing loss was made up of adults with hearing thresholds changed from 25 to 60 dB HL for the frequencies 2000-8000 Hz for pure tone audiometry.

Exclusion criteria

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Universidade Estadual de Ciências da Saúde de Alagoas

Other

Registry information

Important dates

First posted: May 27, 2010
Registry last updated: May 27, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed